​​Pharmaceutical companies prepare documentation at the request of the Norwegian Medicines Agency. The documentation is submitted by e-mail to:
post@noma.no, with a copy to either blaresept@noma.no (for pharmaceuticals to be funded by the "folketrygden") or sykehus@noma.no (for pharmaceuticals to be funded by the  hospitals). It is important to include the following information in the e-mail text: Brand name/trade name, Active substance, and Nordic package number covered by the documentation.

The Norwegian Medicines Agency has prepared guidelines for the duty of confidentiality (STA) under the existing legislation .



Publisert: 16.01.2019

​Fant du det du lette etter?